Drugs / CBT-004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04884256 | Dec 2023 → Apr 2025 | pinguecula | Cloudbreak Therapeutics, LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBT-004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04884256 ↗ |